Aug 1 |
Biogen Inc. 2024 Q2 - Results - Earnings Call Presentation
|
Aug 1 |
Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
|
Aug 1 |
Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall
|
Aug 1 |
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
|
Aug 1 |
Biogen Non-GAAP EPS of $4.02 misses by $0.01, revenue of $2.46B beats by $70M
|
Aug 1 |
Biogen lifts profit forecast, signals progress in turnaround effort
|
Aug 1 |
As sales climb, Biogen ‘convinced’ the worst is over for Leqembi
|
Jul 31 |
Biogen Q2 2024 Earnings Preview
|
Jul 31 |
Biogen, Beckman Coulter and Fujirebio partner to develop Alzheimer’s Tau blood test
|
Jul 31 |
Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
|